Synonyms Ulcerative colitis, active moderate |
Introduction- |
Target |
Mechanism IL-12 inhibitors [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date31 Oct 2023 |
Target |
Mechanism EDG6 agonists [+2] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date12 Oct 2023 |
Target |
Mechanism IL-23p19 inhibitors [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. JP |
First Approval Date27 Mar 2023 |
Start Date17 Nov 2022 |
Start Date15 Dec 2019 |
Sponsor / Collaborator |
Start Date04 May 2017 |
Sponsor / Collaborator |